» Articles » PMID: 36551829

Natural Compounds That Enhance Motor Function in a Mouse Model of Muscle Fatigue

Overview
Journal Biomedicines
Date 2022 Dec 23
PMID 36551829
Authors
Affiliations
Soon will be listed here.
Abstract

Musculoskeletal disease can be a serious condition associated with aging that may lead to fractures and a bedridden state due to decreased motor function. In addition to exercise training to increase muscle mass, increasing muscle function with the intake of functional foods is an effective treatment strategy for musculoskeletal disease. Muscle-specific SOD2-deficient mice (muscle-) show a severe disturbance in exercise in association with increased mitochondrial reactive oxygen species, as well as mitochondrial dysfunction and muscle damage. In the present study, to develop a therapeutic strategy for musculoskeletal disease, we searched for substances that enhanced motor function among functional compounds by in vivo screening using muscle- mice as a muscle fatigue model. We administered 96 compounds, including antioxidants, to muscle- mice and assessed their effects on treadmill performance. Among the administered compounds, gossypin, genistein, kaempferol, taxifolin, fumaric acid, β-hydroxy-β-methylbutyrate Ca, and astaxanthin, which are dietary functional food factors, increased forced running time in muscle- mice. In addition, troglitazone, tempol, trolox, and MnTE-2-PyP, which are antioxidants, also significantly increased the running ability of muscle- mice. These results suggest that the intake of functional foods with antioxidant activity can improve motor function. Muscle- mice, as a muscle fatigue model, are suitable for the in vivo screening of functional substances that promote improvements in exercise and muscle performance.

Citing Articles

Mitochondrial Redox Status Regulates Glycogen Metabolism via Glycogen Phosphorylase Activity.

Sakamoto I, Shibuya S, Nojiri H, Takeno K, Nishimune H, Yaku K Antioxidants (Basel). 2024; 13(11).

PMID: 39594562 PMC: 11590902. DOI: 10.3390/antiox13111421.


Musculoskeletal Diseases: From Molecular Basis to Therapy.

Belluzzi E, Pozzuoli A, Ruggieri P Biomedicines. 2024; 12(1).

PMID: 38255139 PMC: 10813464. DOI: 10.3390/biomedicines12010032.

References
1.
Wilson J, Fitschen P, Campbell B, Wilson G, Zanchi N, Taylor L . International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 2013; 10(1):6. PMC: 3568064. DOI: 10.1186/1550-2783-10-6. View

2.
Roy A, Sharma A, Nellore K, Narkar V, Kumar A . TAK1 preserves skeletal muscle mass and mitochondrial function through redox homeostasis. FASEB Bioadv. 2020; 2(9):538-553. PMC: 7475301. DOI: 10.1096/fba.2020-00043. View

3.
Zanchi N, Gerlinger-Romero F, Guimaraes-Ferreira L, de Siqueira Filho M, Felitti V, Lira F . HMB supplementation: clinical and athletic performance-related effects and mechanisms of action. Amino Acids. 2010; 40(4):1015-25. DOI: 10.1007/s00726-010-0678-0. View

4.
Oshida Y, Kako M, Nakai N, Shimomura Y, Li L, Sato J . Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats. Endocr J. 2000; 46(5):723-30. DOI: 10.1507/endocrj.46.723. View

5.
Kunnumakkara A, Nair A, Ahn K, Pandey M, Yi Z, Liu M . Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood. 2007; 109(12):5112-21. PMC: 1890830. DOI: 10.1182/blood-2007-01-067256. View